XML 21 R6.htm IDEA: XBRL DOCUMENT

General information	12 Months Ended
General information	Jun. 30, 2021
Text block [abstract]
General information	Note 1. General information The financial statements cover Kazia Therapeutics Limited as a consolidated entity consisting of Kazia Therapeutics Limited and its subsidiaries. The financial statements are presented in Australian dollars, which is Kazia Therapeutics Limited’s functional and presentation currency. Kazia Therapeutics Limited is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered office and principal place of business is: Three International Towers Level 24, 300 Barangaroo Avenue Sydney NSW 2000 T h e financial statements were authorised for issue, in accordance with a resolution of Directors, on 7 October 2021. The Directors have the power to amend and reissue the financial statements.